Weihai Baihe Biology Technological Co., Ltd. (SHA:603102)
China flag China · Delayed Price · Currency is CNY
37.77
-1.95 (-4.91%)
At close: Aug 24, 2026

SHA:603102 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
118.63128.43139.31169.07137.84148.04
Depreciation & Amortization
52.9145.8841.1737.5633.1223.76
Other Amortization
2.261.73----
Loss (Gain) From Sale of Assets
-0.04--0.14-0.06-0.270
Asset Writedown & Restructuring Costs
0.010.010.010.345.664.22
Loss (Gain) From Sale of Investments
-1.08-1.05-1.26-1.11-0.42-
Provision & Write-off of Bad Debts
0.850.31.260.140.371
Other Operating Activities
20.75.02-11.59-9.8-15.11-0.41
Change in Accounts Receivable
-14.04-0.72-52.14-8.93-22.86-10.4
Change in Inventory
-6.9-6.96.416.92-41-31.59
Change in Accounts Payable
2.9414.54.31-10.1955.8234.21
Operating Cash Flow
169.28186.02127.65193.85152.91169.15
Operating Cash Flow Growth
23.76%45.73%-34.15%26.78%-9.60%12.77%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-41.74-55.66-94.92-96.52-51.54-124.55
Sale of Property, Plant & Equipment
0.020.020.280.250.610
Cash Acquisitions
-58.41-58.41----
Divestitures
---0.090.08-
Investment in Securities
--10----
Other Investing Activities
11.114.3614.7515.58.911.71
Investing Cash Flow
-89.03-109.7-79.89-80.68-41.95-122.83

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--2.1-2.18-1.37-2.62-1.29
Net Debt Issued (Repaid)
-4.59-2.1-2.18-1.37-2.62-1.29
Issuance of Common Stock
----616.06-
Repurchase of Common Stock
-26.81-30.03-0.61-38.25--
Common Dividends Paid
-46.71-46.71-47.23-38.4-32-14.4
Other Financing Activities
-0.414.75---13.56-
Financing Cash Flow
-78.51-74.08-50.02-78.02567.87-15.69

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-7.15-3.131.260.796.67-1.15
Net Cash Flow
-5.42-0.88-135.95685.529.48

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
127.53130.3632.7397.33101.3644.6
Free Cash Flow Growth
164.27%298.29%-66.37%-3.98%127.25%-61.56%
Free Cash Flow Margin
12.83%14.31%4.08%11.17%13.98%6.74%
Free Cash Flow Per Share
2.072.080.511.521.620.93
Levered Free Cash Flow
66.3467.58-1.2750.3352.3314.38
Unlevered Free Cash Flow
67.0867.77-1.2250.3952.4114.48

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
66.8959.1758.864.3841.5155.42
Change in Working Capital
-24.985.7-41.11-2.28-8.29-7.45